A leading immuno-oncology biotech company with a pipeline of novel, first-in-class clinical stage assets needed medical support for multiple clinical and medical affairs activities in Europe and the United States.


Our support included providing advice and assistance with the following:

  • clinical strategy and execution of the clinical development plans for the company’s drug candidates
  • drug safety and pharmacovigilance
  • fostering existing and future relationships with key opinion leaders, medical advisors and medical advisory boards.

We also assessed portfolio expansion opportunities and other corporate development activities from a clinical development and medical perspective.


View Additional Immunotherapy Case Studies



For more information on how we can assist your project, please contact us.

Related Case Studies